Acalabrutinib in Patients (pts) with Waldenstrom Macroglobulinemia (WM)

Owen, Roger; McCarthy, Helen; Rule, Simon; D'Sa, Shirley; Thomas, Sheeba; Forconi, Francesco; Anderson, Thomas; Kersten, Marie Jose; Zinzani, Pier Luigi; Iyengar, Sunil; Kothari, Jaimal; Minnema, Monique; Kastritis, Efstathios; Izumi, Raquel; Slatter, J. Greg; Mittag, Diana; Wei, Helen; Chen, Dih-Yin; Patel, Priti; Furman, Richard R.

Acalabrutinib in Patients (pts) with Waldenstrom Macroglobulinemia (WM)

DSpace/Manakin Repository

Acalabrutinib in Patients (pts) with Waldenstrom Macroglobulinemia (WM)

Owen, Roger; McCarthy, Helen; Rule, Simon; D'Sa, Shirley; Thomas, Sheeba; Forconi, Francesco; Anderson, Thomas; Kersten, Marie Jose; Zinzani, Pier Luigi; Iyengar, Sunil; Kothari, Jaimal; Minnema, Monique; Kastritis, Efstathios; Izumi, Raquel; Slatter, J. Greg; Mittag, Diana; Wei, Helen; Chen, Dih-Yin; Patel, Priti; Furman, Richard R.

(2018) Clinical Lymphoma, Myeloma and Leukemia, volume 18, pp. S285 - S286

(Abstract)

Download/Full Text

The full text of this publication is not available.

Keywords: Waldenström macroglobulinemia, acalabrutinib, relapsed, refractory, treatment-naïve, BTK inhibitor

ISSN: 2152-2650

Publisher: Cancer Media Group